Acute Coronary Syndrome - Nursing Case Study
Pathophysiology
• Primary mechanism: Rupture of an atherosclerotic plaque in a coronary artery exposes underlying lipid-rich core, triggering platelet activation and aggregation, leading to thrombus (blood clot) formation that obstructs blood flow to the heart muscle.
• Secondary mechanism: Vasoconstriction of the coronary artery, often exacerbated by the release of vasoactive substances from activated platelets, further reduces blood flow and oxygen supply to the myocardium, worsening ischemia.
• Key complication: Myocardial ischemia can progress to infarction, causing necrosis of heart tissue, which impairs cardiac function and can lead to heart failure, arrhythmias, or sudden cardiac death if not promptly managed.
Patient Profile
Demographics:
63-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Metformin 500 mg BID, Lisinopril 20 mg daily, Simvastatin 40 mg daily, Aspirin 81 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe chest pain radiating to the left arm
• Key symptoms: Shortness of breath, diaphoresis, nausea, dizziness
• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths/min, temperature 98.6°F, oxygen saturation 91% on room air
Section 1
As the initial assessment unfolds, the healthcare team quickly administers supplemental oxygen to improve the patient’s oxygen saturation, which rises slightly to 94% with 2 liters per minute via nasal cannula. An electrocardiogram (ECG) is performed, revealing ST-segment elevation in the anterolateral leads, indicative of acute myocardial infarction (MI). Blood samples are drawn for cardiac biomarkers, and the results show elevated troponin levels, confirming myocardial injury. The patient is given sublingual nitroglycerin, which slightly alleviates the chest pain, and IV morphine is administered to further manage pain and anxiety.
Despite these interventions, the patient's condition takes a challenging turn as he begins to exhibit signs of heart failure. The nurse notes bilateral crackles upon auscultation of the lungs, indicating pulmonary congestion, and the patient's respiratory rate increases to 28 breaths per minute. Jugular venous distention is observed, suggesting increased central venous pressure. The patient’s blood pressure drops to 135/85 mmHg, and he appears more fatigued and confused. A chest X-ray confirms pulmonary edema, and the clinical team identifies the need for immediate diuretic therapy to manage fluid overload, alongside continuous monitoring in the intensive care unit.
These developments necessitate a more aggressive therapeutic approach and close monitoring for potential arrhythmias, given the risk of further ischemic complications. The healthcare team considers the initiation of an ACE inhibitor infusion to manage afterload reduction and prevent further cardiac remodeling, while also planning for possible revascularization procedures. This evolving scenario demands prompt clinical reasoning to prioritize interventions, mitigate complications, and stabilize the patient's condition, setting the stage for the next critical phase of his treatment.
Section 2
As the patient's condition continues to be closely monitored in the intensive care unit, the healthcare team observes a change in his status that necessitates immediate attention. Over the next few hours, the patient's oxygen saturation begins to decline despite supplemental oxygen, dropping to 88% on 4 liters per minute via nasal cannula. His respiratory rate remains elevated at 30 breaths per minute, and he exhibits increasing dyspnea. The nurse notes that the bilateral crackles in his lungs have worsened, and the patient is now exhibiting peripheral cyanosis, indicating inadequate tissue perfusion.
A repeat ECG is performed, revealing new-onset atrial fibrillation with a rapid ventricular response, further complicating the patient’s hemodynamic stability. His heart rate spikes to 140 beats per minute, contributing to his hypotension with a blood pressure now at 110/70 mmHg. The medical team quickly recognizes the need to control his heart rate and improve cardiac output. A beta-blocker is cautiously introduced to manage the atrial fibrillation, while ensuring careful monitoring of blood pressure and heart function.
In parallel, laboratory results show a further increase in troponin levels, emphasizing ongoing myocardial injury. The worsening pulmonary edema and the new arrhythmia underscore the critical need for timely intervention to prevent further deterioration. An urgent echocardiogram is scheduled to assess left ventricular function and guide further therapeutic decisions, such as the potential need for mechanical circulatory support. The team deliberates the possibility of urgent coronary angiography to identify and address any obstructive lesions contributing to the acute coronary syndrome. These developments underscore the complexity of the patient’s condition, requiring vigilant clinical reasoning to prioritize interventions and stabilize his fragile status.
Section 3
As the medical team continues to address the patient's complex presentation, they observe a significant change in his status that prompts further evaluation. Despite the introduction of a beta-blocker to manage his atrial fibrillation, the patient’s heart rate remains elevated, fluctuating between 120 and 130 beats per minute. His blood pressure further declines to 100/65 mmHg, raising concerns about compromised cardiac output and tissue perfusion. In light of these changes, the patient’s mental status becomes altered, with an increased level of agitation and confusion, suggesting cerebral hypoperfusion.
The urgent echocardiogram reveals a severely reduced left ventricular ejection fraction of 30%, indicating significant systolic dysfunction. Additionally, moderate mitral regurgitation is noted, likely contributing to the worsening pulmonary edema. The team recognizes that the patient's hemodynamic instability is multifactorial, driven by the combination of decreased myocardial contractility, arrhythmia-induced impairment of cardiac output, and increased preload from fluid overload.
In response to these findings, the healthcare team deliberates the next steps to stabilize the patient's condition. Given the persistent hemodynamic instability and decreased ejection fraction, they consider initiating an inotropic agent to enhance cardiac contractility while continuing to manage the arrhythmia. The possibility of urgent coronary angiography remains on the table to identify any reversible ischemic contributors to the acute coronary syndrome. The complexity of the patient's status underscores the need for a multidisciplinary approach, integrating cardiology, critical care, and nursing expertise to prioritize and implement interventions that will optimize cardiac function and prevent further deterioration.
Section 4
As the healthcare team initiates inotropic therapy to improve the patient's cardiac contractility, they closely monitor the patient's response. Within the first few hours, there is a modest improvement in cardiac output, with the heart rate slightly decreasing to 110-115 beats per minute. However, the blood pressure remains low, fluctuating around 95/60 mmHg, indicating persistent hemodynamic instability. The patient continues to exhibit signs of agitation and confusion, suggesting ongoing cerebral hypoperfusion. In an attempt to further evaluate the underlying cardiac issues, a repeat set of laboratory tests is ordered.
The lab results reveal an increase in serum troponin levels, indicating continued myocardial injury, and a rise in B-type natriuretic peptide (BNP), consistent with heart failure exacerbation. Additionally, arterial blood gas analysis shows a mild metabolic acidosis, with a pH of 7.32 and bicarbonate level of 18 mEq/L, which may be related to poor perfusion and lactic acid buildup. These findings highlight the need to reassess the current management plan and consider additional interventions to address the underlying ischemia and fluid overload contributing to the patient's condition.
Given the persistent instability and evidence of ongoing myocardial damage, the team decides to proceed with urgent coronary angiography. This decision is made to identify any critical coronary artery lesions amenable to intervention, which could potentially improve cardiac function and stabilize the patient's condition. As preparations are made for the procedure, the team emphasizes the importance of maintaining close monitoring of the patient's vital signs and mental status, recognizing that timely identification and management of any new complications will be crucial to improving outcomes.
Section 5
As the patient is prepared for urgent coronary angiography, the healthcare team notes a sudden change in the patient's status. The patient's respiratory rate increases to 28 breaths per minute, and the oxygen saturation drops to 88% on room air, prompting the initiation of supplemental oxygen. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary edema, likely secondary to acute heart failure exacerbation. The patient becomes increasingly diaphoretic and pale, with complaints of worsening chest discomfort. The heart rate climbs again, this time to 125 beats per minute, and the blood pressure further declines to 85/55 mmHg, indicating worsening hemodynamic compromise.
In response to these developments, the medical team quickly reassesses the patient's volume status and considers the administration of diuretics to manage the fluid overload. However, the persistent hypotension poses a challenge, necessitating careful titration of inotropic support to maintain cardiac output without exacerbating the hypoperfusion. The increasing troponin levels and B-type natriuretic peptide continue to reflect significant myocardial stress and left ventricular dysfunction. The team also decides to initiate a low-dose norepinephrine infusion to support blood pressure, balancing the need to optimize perfusion against the risk of increased myocardial oxygen demand.
These clinical changes underscore the complexity of the patient's condition and the need for a multifaceted approach to management. As the patient is transported to the catheterization lab, the team remains vigilant for signs of acute coronary syndrome complications, such as arrhythmias or cardiogenic shock. The upcoming angiography is anticipated to provide critical insights into the coronary anatomy, guiding further intervention strategies to stabilize the patient and mitigate the risk of further myocardial damage. Meanwhile, ongoing communication among the healthcare providers is essential to ensure seamless coordination of care and prompt response to any arising complications.